348 results on '"Harrop R"'
Search Results
2. An Intersection Property in Locally Convex Spaces
3. Feeding ecology of herring (Clupea harengus) larvae in the turbid Blackwater Estuary
4. 838P TRIOC-A randomised phase II trial to examine MVA-5T4 vaccine in patients with relapsed asymptomatic epithelial ovarian, fallopian tube or primary peritoneal cancer
5. Dynamic SPECT imaging using a single camera rotation (dSPECT)
6. An investigation of the propositional calculus used in a particular system of logic
7. Effect of Modified Vaccinia Ankara–5T4 and Low-Dose Cyclophosphamide on Antitumor Immunity in Metastatic Colorectal Cancer: A Randomized Clinical Trial
8. Dynamic heat-in-thorax phantom for functional SPECT
9. Quantitative 3D data extraction using contiguous volumes
10. Reconstruction of multiple line source attenuation maps
11. Experimental validation of an analytical method of calculating SPECT projection data
12. Phase II studies of MVA expressing the tumour antigen 5T4 given with 5-FU based chemotherapies: safety, immunogenicity and clinical responses: 10.9
13. Identification and functional validation of MHC Class I epitopes in the tumour-associated antigen 5T4: 10.8
14. Feeding dynamics of fish larvae on Copepoda in the western Irish Sear with particular reference to cod Gadus morhua
15. The Incorporation of Organ Uptake into Dynamic SPECT (dSPECT) Image Reconstruction
16. Analytical Calculations of Cross-Talk for Dual-Isotope SPECT Projections
17. An Introduction to the Method of Characteristics : An A.R.C. Paper in which the Method is Developed from Elementary Physical Considerations
18. On disjunctions and existential statements in intuitionistic systems of logic
19. Some Forms of Models of Propositional Calculi
20. A novel series of conferences tackling the hurdles confronting the translation of novel cancer immunotherapies
21. Identification of pre- and post-treatment markers of efficacy in patients with renal cancer treated with MVA-5T4 in a phase III study.
22. Positron emission tomography in the early diagnosis of Huntingtonʼs disease
23. Cytolytic effects of CD8+ CTL clones specific for an HLA-A2 epitope from the 5T4 tumor antigen on tumor cells in vitro.
24. Clinical and laboratory parameters associated with outcomes in patients with metastatic renal cell carcinoma treated with modified vaccinia Ankara delivering tumor antigen 5T4.
25. 17LBA TRIST: A randomised, double blind, placebo controlled phase III study of MVA-5T4 in metastatic renal cancer patients
26. Vaccination of renal cell cancer (RCC) patients with modified vaccinia Ankara (MVA) delivering tumor antigen 5T4 administered alone or with interleukin 2 (IL-2) or interferon-alpha (IFN)
27. Analysis of immunological and clinical data resulting from four phase I and II trials of MVA-5T4 in colorectal cancer patients
28. 601 POSTER Cross-trial analysis of immunological and clinical data resulting from phase I and II trials of MVA-5T4 (TroVax®) in colorectal, renal and prostate cancer patients
29. An MVA based vaccine targeting the oncofoetal antigen 5T4 in patients undergoing surgical resection of colorectal cancer liver metastases
30. 5T4-specific antibody responses are associated with survival in a phase II trial of renal cell carcinoma patients vaccinated with modified vaccinia Ankara delivering the tumour antigen 5T4 in combination with low-dose IL-2
31. Identification and functional validation of MHC class I epitopes in the tumor-associated antigen 5T4
32. Vaccination of renal cell cancer patients with TroVax (modified vaccinia Ankara delivering the tumor antigen 5T4) plus IFNα: A phase II trial
33. Correlation of effector and regulatory T cell responses with clinical outcome in metastatic renal cell carcinoma patients treated with MVA-5T4 vaccine and high-dose interleukin-2
34. Vaccination of renal cell cancer (RCC) patients with modified vaccinia ankara delivering the tumor antigen 5T4 (TroVax [T]) administered + low dose interleukin-2 (IL-2): A phase II trial
35. The oncofetal protein, 5T4, is a suitable target for antibody-guided anti-cancer chemotherapy with calicheamicin
36. Activity of MVA 5T4 alone or in combination with either interleukin-2 (IL-2) or interferon-α (IFN) in patients (Pts) with metastatic renal cell cancer (MRCC)
37. Hydrophilation of glass surfaces II Reaction of quaternary ammonium compounds with surface hydroxyl groups
38. Hydrophilation of glass surfaces I. Investigation of possible promoters of filmwise condensation
39. 117 POSTER Activity of MVA 5T4 alone or in combination with either Interleukin-2 (IL-2), Interferon-alpha (IFN), or Sunitinib in patients (Pts) with Metastatic Renal Cell Cancer (MRCC)
40. 113 POSTER Phase II trial to assess the activity of MVA5T4 (Trovax®) alone versus MVA5T4 plus granulocyte macrophage colony-stimulating factor (GM-CSF) in patients (pts) with progressive hormone refractory prostate cancer (HRPC)
41. A phase II trial to assess the activity of MVA5T4 plus interleukin-2 in patients (Pts) with metastatic renal cell carcinoma (MRCC)
42. A vaccinia-based vaccine (TroVax) targeting the oncofetal antigen 5T4 administered before and after surgical resection of colorectal cancer liver metastases: Phase II trial
43. Open label phase II studies of modified vaccinia ankara expressing the tumor antigen 5T4 given in conjunction with IFL and FOLFOX chemotherapy regimens: Final analysis of safety and immunogenicity of MVA 5T4 given before, during and after chemotherapy
44. A phase I clinical trial of MVA expressing 5T4 and high-dose interleukin-2 (IL-2) for metastatic renal cell carcinoma
45. Point/Counterpoint
46. An open label phase II study of modified vaccinia ankara (MVA) expressing the tumor antigen 5T4 given in conjunction with chemotherapy: Safety and immunogenicity before, during and after chemotherapy
47. EPIDEMIOLOGY OF SEVERE TRAUMA AMONG TREATY STATUS FIRST NATIONS IN THE CALGARY HEALTH REGION
48. 961 Phase I study of escalating doses of TroVax® in patients wtih advanced colorectal cancer (CRC)
49. The schistosome egg: development and secretions
50. Experimental verification of 3D detector response compensation using the OSEM reconstruction method.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.